Clinical trial
Regulation of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide (Victoza)
NCT02201550 is registered in ClinicalTrials.gov with Hvidovre University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Regulation of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide (Victoza)
- Lead sponsor
- Hvidovre University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- April 30, 2014
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes mellitus